Probiotics are one of the better-selling categories within the VMS space, with more consumers researching probiotics online and coming to the store with a specific brand in mind, according to i-Health market intelligence.
The Vitamin Shoppe for the past year has been steadily redefining the brick-and-mortar experience for natural health shoppers via its latest store prototype, the Brand Defining Store, attracting three times the number of first-time customers through its doors.
For decades, chain and independent retail pharmacy has been defined by its unyielding pursuit of professional recognition, fair reimbursement and full status as a member of the healthcare provider team. The industry has made huge strides toward that goal, thanks to massive investments in pharmacy technology and automation.
From large-scale, high-volume processors to “cobots’’ that require a minimal amount of countertop space, a new generation of dispensing tools is allowing pharmacies to shift more of the workload to technicians and central-fill sites.
The growth trends in sales of vitamins and supplements in specialty channels, ranging from natural grocers to gourmet wellness stores, are great harbingers of what might soon be best-selling categories within mass outlets.
Sales of artificial eyelashes packaged with adhesives rose 31% to $157 million, according to IRI data for multi-outlet retailers for the 52-week period ended March 19. Eyelash adhesives kicked in another $30 million and showed growth of 24%.
Drug and discount stores have managed to lure customers away from specialty and department stores to their doors for color cosmetics, where brows and lashes are leading the charge to attract shoppers, skin care and bubble bath products.
As more Americans wrestle with the cost of their health care, they continue to gravitate toward better lifestyle choices, which means niche products that were at one time only purchased by body builders and serious athletes have become appealing to the mainstream consumer.
One of the biggest trends in food and beverage in the past several years has been in better-for-you offerings — something that’s expected to continue to influence new products as consumers remain focused on what’s in their favorite snacks and beverages.
Although 2016 saw the Food and Drug Administration approve only 22 new drugs compared with 45 approvals in 2015 and the lowest tally since 2010, many in the pharmaceutical arena remain optimistic that this year will see a reversal of that trend.
Legislation pending in both houses of Congress regarding DIR, or direct and indirect remuneration, fees are giving hope to drug stores and two of the industry’s largest advocacy groups that pharmacy benefits management companies will stop retroactively reducing payments.
There is no question that one of the top nonprescription categories contributing to both sales and foot traffic right now is allergy. Sales of nasal sprays — the category that captures all of the latest nasal corticosteroid Rx-to-OTC switches — are up 10.2%.
This could be the year. Movement again is occurring in Congress on legislation that would confer professional provider status on pharmacists serving millions of older Americans in many parts of the country.